Чешка - Чешки - SUKL (Státní ústav pro kontrolu léčiv)

heaton k.s., praha array - 17229 cinakalcet-hydrochlorid - potahovaná tableta - 30mg - cinakalcet

Чешка - Чешки - SUKL (Státní ústav pro kontrolu léčiv)

heaton k.s., praha array - 17229 cinakalcet-hydrochlorid - potahovaná tableta - 60mg - cinakalcet

Европска Унија - Чешки - EMA (European Medicines Agency)

zoetis belgium sa - synthetic peptide analogue of gnrf conjugated to diptheria toxoid - imunologická vyšetření pro suidae - male pigs (from 8 weeks of age); female pigs (from 14 weeks of age) - male pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of testicular function. for use as an alternative to physical castration for the reduction of boar taint caused by the key boar taint compound androstenone, in entire male pigs following the onset of puberty. dalším klíčovým přispěvatelem k odřeninám, skatolem, může být i nepřímý účinek. agresivní a sexuální (montážní) chování jsou také sníženy. female pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of ovarian function (suppression of oestrus) in order to reduce the incidence of unwanted pregnancies in gilts intended for slaughter, and to reduce the associated sexual behaviour (standing oestrus).

Европска Унија - Чешки - EMA (European Medicines Agency)

n.v. organon - korifolitropin alfa - reproductive techniques, assisted; ovulation induction; investigative techniques - pohlavní hormony a modulátory genitálního systému, - controlled ovarian stimulation (cos) in combination with a gnrh antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (art) program. elonva is indicated for the treatment of adolescent males (14 to less than 18 years and older) with hypogonadotropic hypogonadism, in combination with human chorionic gonadotropin (hcg).

Чешка - Чешки - SUKL (Státní ústav pro kontrolu léčiv)

+pharma arzneimittel gmbh, graz array - 11701 leuprorelin-acetÁt - prášek a rozpouštědlo pro injekční suspenzi s prodlouženým uvolňováním - 22,5mg - leuprorelin

Европска Унија - Чешки - EMA (European Medicines Agency)

novo nordisk a/s - somapacitan - růst - hypofýzy a hypotalamické hormony a analogy - sogroya is indicated for the replacement of endogenous growth hormone (gh) in children  aged 3  years and above, and adolescents with growth failure due to growth hormone deficiency (paediatric ghd), and in adults with growth hormone deficiency (adult ghd).

Европска Унија - Чешки - EMA (European Medicines Agency)

astellas pharma europe b.v. - enzalutamid - prostatetické novotvary - endokrinní terapie - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Европска Унија - Чешки - EMA (European Medicines Agency)

janssen-cilag international nv - apalutamide - prostatetické novotvary - endokrinní terapie - erleada je indikován:u dospělých mužů k léčbě non metastatického kastraci rezistentní karcinom prostaty (nmcrpc), kteří jsou na vysoké riziko vzniku metastazujícího onemocnění. u dospělých mužů k léčbě metastatického hormon-senzitivní rakoviny prostaty (mhspc) v kombinaci s androgen deprivační terapie (adt).

Чешка - Чешки - SUKL (Státní ústav pro kontrolu léčiv)

adamed pharma s.a., czosnów array - 15483 dutasterid - měkká tobolka - 0,5mg - dutasterid

Чешка - Чешки - SUKL (Státní ústav pro kontrolu léčiv)

glaxosmithkline (ireland) limited, dublin array - 15483 dutasterid - měkká tobolka - 0,5mg - dutasterid